Nausea is the most frequent side effect, typically emerging within hours to days of the first injection and often improving after 24 weeks as your body adjusts
Kuo B, Karlson R, Clukey J, Beck V, Ziyang JK, Corradini GM, Dekel M, Lojacono G, Nuako A, Peterson B, Somlo D, Bar N, Hobai I (2024) P0678 - clinical impact of GLP-1RA on endoscopy: a retrospective cohort study in endoscopy patients
Find detailed results here: #obesity #GLP1 The Obesity Society NG101 reduces nausea and vomiting in semaglutide study -1 : Our Phase 2 clinical study of NG101 for semaglutide-induced nausea and vomiting showed that NG101 reduced the incidence of nausea by 40% and decreased the incidence of vomiting by 67%, compared to placebo
TODAY (@TODAYshow) September 20, 2024 Several forces are now converging: Strong clinical evidence supporting GLP-1 effectiveness Rising patient demand for weight and metabolic health treatments Federal pressure to reduce drug prices Potential expansion of insurance coverage If coverage expands significantly, utilization will almost certainly rise further
Serious side effects are rare but can include pancreatitis and gallbladder issues
We blend that with sensible natural care